Maxnerva Technology Services Limited (HKG:1037) announced strong profits, but the stock was stagnant. Our analysis suggests that shareholders have noticed something concerning in the numbers.
See our latest analysis for Maxnerva Technology Services
SEHK:1037 Earnings and Revenue History October 6th 2022
How Do Unusual Items Influence Profit?
For anyone who wants to understand Maxnerva Technology Services' profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from CN¥18m worth of unusual items. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's as you'd expect, given these boosts are described as 'unusual'. Maxnerva Technology Services had a rather significant contribution from unusual items relative to its profit to June 2022. All else being equal, this would likely have the effect of making the statutory profit a poor guide to underlying earnings power.
Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Maxnerva Technology Services.
Our Take On Maxnerva Technology Services' Profit Performance
As we discussed above, we think the significant positive unusual item makes Maxnerva Technology Services' earnings a poor guide to its underlying profitability. As a result, we think it may well be the case that Maxnerva Technology Services' underlying earnings power is lower than its statutory profit. The good news is that, its earnings per share increased by 69% in the last year. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. To help with this, we've discovered 3 warning signs (1 doesn't sit too well with us!) that you ought to be aware of before buying any shares in Maxnerva Technology Services.
This note has only looked at a single factor that sheds light on the nature of Maxnerva Technology Services' profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Maxnerva科技服务有限公司(HKG:1037)公布强劲盈利,但股价停滞不前。我们的分析表明,股东们注意到了数字中的一些令人担忧的地方。
查看我们对Maxnerva技术服务的最新分析
联交所:1037盈利及收入历史2022年10月6日
不寻常的项目如何影响利润?
对于任何想要了解Maxnerva技术服务公司超出法定数字的利润的人来说,重要的是要注意到,在过去的12个月里,从CN价值1800万元的不寻常项目中获得了法定利润。虽然有更高的利润总是好事,但不寻常的东西带来的巨大贡献有时会挫伤我们的热情。当我们分析全球绝大多数上市公司时,我们发现重大的不寻常项目往往不会重复。考虑到这些提振被描述为“不寻常的”,这正如你所预期的那样。Maxnerva技术服务公司在截至2022年6月的利润中,来自不寻常项目的贡献相当大。在其他条件不变的情况下,这可能会使法定利润成为衡量潜在盈利能力的糟糕指标。
注:我们总是建议投资者检查资产负债表的实力。单击此处查看我们对Maxnerva技术服务的资产负债表分析。
我们对Maxnerva技术服务公司盈利表现的看法
正如我们上面讨论的,我们认为重大的积极的不寻常项目使Maxnerva Technology Services的收益不能作为其潜在盈利能力的糟糕指南。因此,我们认为Maxnerva Technology Services的潜在盈利能力很可能低于其法定利润。好消息是,它的每股收益在去年增长了69%。归根结底,如果你想正确地了解这家公司,除了以上几个因素之外,考虑其他因素也是至关重要的。考虑到这一点,除非我们对风险有透彻的了解,否则我们不会考虑投资股票。为了帮助解决这个问题,我们发现3个警示标志(%1与我们的关系不太好!)在购买Maxnerva Technology Services的任何股票之前,您应该意识到这一点。
这份报告只关注了一个因素,它揭示了Maxnerva Technology Services的利润性质。但还有很多其他方式可以让你了解一家公司的看法。一些人认为,高股本回报率是高质量企业的良好标志。虽然这可能需要为您做一些研究,但您可能会发现免费拥有高股本回报率的公司的集合,或者是内部人士购买的有用的股票清单。
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。